VEGF121 / VEGF-A抗体

VEGF121 / VEGF-A抗体产品信息免疫原 : Recombinant Human VEGF121 / VEGF-A protein (Catalog#10008-HNAB)

Antibody Type : Rabbit Polyclonal Antibody ( Antibody Purification Platform )
抗体宿主 : Rabbit IgG
缓冲液 : 0.2 μm filtered solution in PBS, 5% trehalose may be added in some batches. Please read the hardcopy of COA or contact our customer service to confirm the formulation.
制备方法 : Produced in rabbits immunized with purified, recombinant Human VEGF121 / VEGF-A (rh VEGF121 / VEGF-A; Catalog#10008-HNAB; P15692-9; Met 1-Arg 147). VEGF121 / VEGF-A specific IgG was purified by Human VEGF121 / VEGF-A affinity chromatography.
VEGF121 / VEGF-A抗体 Background
Vascular endothelial growth factor (VEGF), also known as vascular permeability factor (VPF) and VEGF-A, is a potent mediator of both angiogenesis and vasculogenesis in the fetus and adult. It is a member of the platelet-derived growth factor (PDGF)/vascular endothelial growth factor (VEGF) family and often exists as a disulfide-linked homodimer. VEGF-A is a glycosylated mitogen that specifically acts on endothelial cells and has various effects, including mediating increased vascular permeability, inducing angiogenesis, vasculogenesis and endothelial cell growth, promoting cell migration, and inhibiting apoptosis. As its name implies, VEGF-A activity has been mostly studied on cells of the vascular endothelium, although it does have effects on a number of other cell types (stimulation monocyte/macrophage, neurons, cancer cells, kidney epithelial cells). VEGF-A is also a vasodilator and increases microvascular permeability and was originally referred to as vascular permeability factor. Alternatively spliced transcript variants of VEGF-A, encoding either secreted or cell-associated isoforms, have been identified. Alternatively spliced isoforms of 121,145,165,183,189 and 206 amino acids in length are expressed in humans. VEGF165 appears to be the most abundant and potent isoform and is a heparin-binding growth factor with mitogenic activity for vascular endothelial cells. Human VEGF165 shares 88%, 96%, 95% and 93% aa sequence identity with mouse, porcine, canine and feline VEGF165, respectively.
VEGF121 / VEGF-A抗体相关产品如下：xy-1628xy CXCR6(CXC-chemokine receptor 6) peptide细胞表面趋化因子受体6抗原
xy-1305xy CCR-7(CC chemokine receptor 7)CC趋化因子受体7（多肽）
xy-1502xy CXCL10/IP-10CXCL10趋化因子10/干扰素诱导蛋白10抗原
xy-0279xy VEGF(Vascular endothelial growth factor)血管内皮生长因子（多肽抗原）
xy-0527xy CD10/CALLA (Neutral Endopeptidase)CD10抗原
xy-0354xy ZCWCC1(Zinc finger CW-type coiled-coil domain protein 1)ZCWCC1抗原
xy-1309xy CD138/Syndecan-1多配体蛋白聚糖1抗原
xy-1618xy CD146/MCAM黑色素瘤细胞粘附分子CD146抗原
xy-1383xy ANPEN/CD13(Aminopeptidase N)氨肽酶N抗原
xy-1192xy CD14(cluster of differentiation antigen 14)CD14/内毒素受体抗原
xy-1297xy CD28CD28抗原
xy-1251xy CD166/ALCAM(activated leukocyte celladhesion molecule)活化白细胞粘附分子抗原
xy-1482xy CD177/NB1 peptide嗜中性粒细胞抗原CD177抗原
xy-0528xy CD24CD24抗原
xy-0512xy CD2AP (CD2-associated protein)白细胞分化抗原CD2AP
xy-1514xy CD33/Siglec-3(mouse ret)CD33抗原(大、小鼠）
xy-2038xy CD34CD34抗原（细胞表面的唾液粘蛋白）
xy-0979xy CD38(mouse, rat)CD38多肽（小鼠、大鼠）
xy-0980xy CD38(human)CD38抗原（人）
xy-1100xy CD36CD36（多肽）
xy-1520xy CD7CD7抗原
xy-1286xy CD40L(CD40 Ligand/TNFSF5/CD154)CD40L抗原
xy-0521xy CD44CD44抗原 (多肽抗原)
Y-0206 Argireline peptide 抗皱寡肽-1/六胜肽-3/阿基瑞林/乙酰六胜肽-3
Y-0207 GHRP-2 Acetate peptide(Growth hormone-releasing peptides 2)醋酸促生长激素释放肽2
Y-0208 GHRP-6 Acetate peptide(Growth hormone-releasing peptides 6)醋酸促生长激素释放肽6
Y-0209 Matrixyl Acetate五胜肽/美容肽—M肽
Y-0210 MT-II(Melanotan II Acetate)醋酸美拉诺坦II
Y-0211 Pentapeptide-3/Leuphasyl五胜肽
Y-0212 PT141(Bremelanotide PT-141)雌性激素肽
xy-0522xy CD45CD45(白细胞共同抗原)
xy-1539xy CD46/MCP(membrane cofactor protein)rat, mouse膜辅蛋白/内源性辅助因子活性蛋白抗原